Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)

Lignende værker

• Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
  af: Robinson, Jennifer G., et al.
  Udgivet: (2014)
• Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
  af: Masadeh, Majed, et al.
  Udgivet: (2012)
• A Randomized Controlled Study to Compare the Effects of Rosuvastatin 5 mg and Atorvastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-2)
  af: Yamazaki, Tsutomu, et al.
  Udgivet: (2010)
• Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia
  af: M Yu Zubareva, et al.
  Udgivet: (2014-06-01)
• Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
  af: Torimoto, Keiichi, et al.
  Udgivet: (2013)